Hospital Infection Therapeutics Market

30 Apr


Hospital Infection Therapeutics Market Poised to Grow at a CAGR of 4.61% by 2024

  • By admin

  • January, 1970

Infinium Global Research has added a new report on Hospital Infection Therapeutics Market. The report presents analysis of global as well as regional markets of hospital infection therapeutics market over the period of 2016 to 2024.

Hospital infections are also referred to as healthcare-associated infections (HCAIs). Healthcare associated infections can be termed as those infections that occur in patients when they are admitted to any healthcare facility or any hospital, with which they were not suffering from at the time of their admission. The growth of the hospital infection therapeutics market is primarily due to increase number of patients admitted to hospitals, growing prevalence of several hospital infections and High number of pipeline drug molecules for specific treatment of healthcare associated infections. Furthermore, lack of knowledge about the blood transfusion safety measures, understaffing, insufficient hospital equipment and poor infrastructure particularly seen in the developing and underdeveloped nations are some of factors responsible for spreading hospital infection which, in turn increases the hospital infection therapeutics market. However, increase number of surveillance and infection control programs by government agencies, hospitals and other medical institutes may restrain the growth of this market.

On the basis of Drug type segment, the antibacterial drugs segment dominated the hospital infection therapeutics market, accounting 2/3rd of the market share among other drug type and is expected to grow at a fast pace during the forecast period. On the basis of type of information, hospital acquired pneumonia has the highest market share among other infection type in the hospital infection therapeutics market. Urinary Tract Infections is expected to grow at the highest CAGR over the forecast period.

Moreover, the growth matrix presented by Infinium Global Research identifies the key investment markets in the near future, this will not only help the companies to understand the competitive position in the global hospital infection therapeutics market  but also make strategic decisions to capture the most lucrative markets in the near future.

The market size is presented in terms of value for the historic year 2016 and estimated for forecast period of 2018-2024.


Get 15% discount for early purchase of global hospital infection therapeutics market report by clicking the following link, Use code IGRD15 to request the discount in the given form


The recent report identified that North America dominated the global hospital infection therapeutics market over the last couple of years, while emerging markets of Asia-Pacific and Latin America are anticipated to contribute significantly to the growth in the hospital infection therapeutics market worldwide.


The report segments the global hospital infection therapeutics market on the basis of By Drug Type and by Major Infections.


Global Hospital Infection Therapeutics Market by Drug Type

·         Antibacterial Drugs

·         Antiviral Drugs

·         Antifungal Drugs


Global Hospital Infection Therapeutics Market by Major Infections

·         Hospital Acquired Pneumonia

·         Surgical Site Infections

·         Urinary Tract Infection

·         Gastrointestinal Disorders

·         Bloodstream Infections

·         Other Hospital Infections


Companies Profiled in the Report

·         Bayer Ag

·         Johnson & Johnson Services Inc.

·         Actavis Plc

·         Sanofi

·         Bristol Myers Squibb Company

·         AstraZeneca Plc

·         Pfizer Inc.

·         Merck & Co, Inc.

·         GlaxoSmithkline Plc

·         Cubist Pharmaceuticals, Inc.


About Infinium Global Research

Infinium Global Research is a business intelligence company that provides its clients with market information services, solutions, and reports. The intelligence reports include qualitative as well as quantitative information, which are blended using forecasting models in order to project future market demand. Our panels of Subject Matter Experts (SMEs), Analysts, and Consultants use numerous data gathering tools in order to provide you with detailed information on the market as well as a preview of its projected growth. Our repository includes the largest and most credible databases, through which we determine various qualitative and quantitative parameters of the market to provide you with an in-depth business intelligence report.

Infinium Global Research reports and consulting services cover numerous sectors, which include healthcare, chemicals, materials, energy, packaged goods, food and beverages, technology, and communications. These reports provide readers with market insights and detailed analysis of market segments to possible micro levels. Our reports, with stratified research methodology and wider scope of analysis, provide clients with crucial insights and information to meet their every requirement.